首页> 外文期刊>Neuropathology: official journal of the Japanese Society of Neuropathology >Polymorphous oligodendroglioma of Zulch revisited: A genetically heterogeneous group of anaplastic gliomas including tumors of bona fide oligodendroglial differentiation
【24h】

Polymorphous oligodendroglioma of Zulch revisited: A genetically heterogeneous group of anaplastic gliomas including tumors of bona fide oligodendroglial differentiation

机译:祖尔氏多形性少突胶质细胞瘤的再探讨:遗传性异质性间变性胶质瘤,包括真正的少突胶质细胞分化肿瘤

获取原文
获取原文并翻译 | 示例
       

摘要

A polymorphous variant of oligodendroglioma was described by K. J. Zulch half century ago, and is only very sporadically referred to in the subsequent literature. In particular, no comprehensive analysis with respect to clinical or genetic features of these tumors is available. From a current perspective, the term polymorphous oligodendroglioma (pO) may appear as contradictory in terms, as nuclear monotony is a histomorphological hallmark of oligodendrogliomas. For the purpose of this study, we defined pO as diffusely infiltrating gliomas felt to be of oligodendroglial rather than astrocytic differentiation and characterized by the presence of multinucleate tumor giant cells and/or nuclear pleomorphism. In a total of nine patients, we identified tumors consistent with this working definition. All tumors were high-grade. We characterized these with respect to clinical, histomorphological and genetic features. Despite clinical and genetic heterogeneity, we identified a subset of tumors of bona fide oligodendroglial differentiation as characterized by combined loss of heterozygosity of chromosome arms 1p and 19q (LOH 1p19q). Those tumors that lacked LOH 1p19q showed a high frequency of IDH1 mutations and loss of alpha thalassemia/mental retardation syndrome X-linked gene (ATRX) immunoreactivity, indicating a possible phenotypic convergence of true oligodendrogliomas and gliomas of the alternative lengthening of telomeres (ALT) pathway. p53 alterations were common irrespective of the 1p19q status. Histomorphologically, the tumors featured interspersed bizarre multinucleate giant tumor cells, while the background population varied from monotonous to significantly pleomorphic. Our findings indicate, that a rare polymorphous - or "giant cell" - variant of oligodendroglioma does indeed exist.
机译:少突胶质细胞瘤的多态性变体由K. J. Zulch在半个世纪前描述,在随后的文献中很少提及。特别是,没有关于这些肿瘤的临床或遗传特征的全面分析。从当前的角度来看,术语多态性少突胶质细胞瘤(pO)可能是矛盾的,因为核单调是少突胶质细胞瘤的组织形态学标志。出于本研究的目的,我们将pO定义为感觉是少突胶质而不是星形胶质细胞分化的弥漫性浸润性神经胶质瘤,其特征是存在多核肿瘤巨细胞和/或核多型性。在总共9例患者中,我们确定了与该工作定义相符的肿瘤。所有肿瘤均为高级别。我们就临床,组织形态学和遗传学特征对它们进行了表征。尽管有临床和遗传上的异质性,我们还是发现了一个真正的少突胶质细胞分化的肿瘤子集,其特征是染色体臂1p和19q(LOH 1p19q)杂合性的综合丧失。那些缺乏LOH 1p19q的肿瘤表现出高频率的IDH1突变和α地中海贫血/智力低下综合征X连锁基因(ATRX)免疫反应丧失,表明真正的少突胶质神经胶质瘤和神经胶质瘤可能在端粒的选择性延长中表现出表型融合途径。不论1p19q的状态如何,p53改变都是常见的。在组织学上,肿瘤的特征是散布着奇异的多核巨肿瘤细胞,而背景种群则从单调到明显的多形。我们的发现表明,确实存在罕见的少突胶质细胞瘤多态性或“巨细胞”变体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号